Established in 1989, The Society of Thoracic Surgeons Adult Cardiac Surgery Database is one of the most comprehensive clinical data registries in health care. It is widely regarded as the gold standard for benchmarking risk-adjusted outcomes in cardiac surgery and is the foundation for all quality measurement and improvement activities of The Society of Thoracic Surgeons. This is the second in a series of annual reports that summarizes current aggregate national outcomes in cardiac surgery and reviews database-related activities in the areas of quality measurement and performance improvement during the past year. he Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) was established in response to the publication of minimally adjusted coronary artery bypass grafting (CABG) operative mortality data by the federal government in 1986 and the recognition by STS leaders that these results did not adjust for differences in the inherent risk of patients [1, 2] . Since its inception in 1989, the primary goal of the ACSD has been to provide clinically relevant and accurate information to STS participants to assist in self-assessment and quality improvement activities.
During the past 3 decades, the ACSD has evolved into the most comprehensive clinical cardiac surgery data registry in the world. Data derived from this repository of more than 6.1 million patient records support nationally benchmarked performance assessment and feedback, sophisticated risk adjustment models [3] [4] [5] , performance measurement [6, 7] , quality improvement initiatives, and voluntary public reporting [8] . The ACSD has also been linked with other registries, facilitating the development of a platform for longitudinal outcomes assessment to inform comparative effectiveness research, device surveillance, and health policy development. This report summarizes current national aggregate cardiac surgical outcomes and outlines quality measurement and performance improvement activities derived from the ACSD during the past year.
Overview of the ACSD
ACSD participants submit data to the STS data warehouse and analytical center at Duke Clinical Research Institute during four quarterly harvests each year. After internal checks for data completeness and consistency are conducted, analyses are performed, and the results are disseminated quarterly to each ACSD participant. The information is participant specific regarding risk factors and nationally benchmarked outcomes and also contains aggregate national results for comparison and internal quality assurance. Semiannually, participants also receive their performance on National Quality Forum (NQF)-endorsed STS measures and composite quality scores based on a running 12 months (CABG) and 36 months (valve) of data ending in June or December of each year.
As of September 2016, the ACSD included 1,119 participant groups comprising 3,100 surgeons from all 50 United States states, 10 sites in Canada, and 19 participants in 7 other countries. The data set contains information on more than 6.1 million cumulative cardiac operations worldwide. The anesthesiology module has 62 participants comprising 684 anesthesiologists. The atrial fibrillation module has 15 participants. Linked Centers for Medicare and Medicaid Services and ACSD CABG data have demonstrated high ACSD patient (94%) and centerlevel (90%) penetration and 98% complete case inclusion of Centers for Medicare and Medicaid Services CABG cases at STS sites [9] . These findings provide reassuring information about the representativeness and completeness of the ACSD.
Data integrity has been of paramount importance to the ACSD since its inception. In addition to an extensive internal validation process, beginning in 2006, STS has randomly selected 10% of sites each year for additional independent external audit. In 2016, 110 facilities were audited. During an audit, submitted data are compared with the medical record, and hospital surgical logs are reviewed to verify that all cases are included. These audits have shown nearly 100% of cases are appropriately captured and that concordance rates with submitted data elements exceed 95% [10, 11] .
Some data fields have a choice of "unknown," as an option to be used only after every effort has been made to ascertain the correct response. Minimizing the use of "unknown" is particularly critical for those fields relating to operative mortality, because they underpin the validity of risk models, benchmarking, and composite scores. The relevant operative mortality fields include "discharge status," "status at 30 days after discharge," and "operative death." To assure the highest level of accuracy when reporting operative mortality, STS has established "missing" or "unknown" vital status thresholds to determine eligibility to receive a composite score (star rating). As of January 1, 2016, fields relating to operative mortality status must have a completeness rate of 95%, increasing to 98% for those cases performed after December 31, 2016. Records with "unknown" or "missing" operative mortality data are considered incomplete. Patients of STS ACSD participants who do not meet data completeness thresholds will not be included in the benchmark population used for performance analyses, and these participants will not be eligible to receive a composite score.
A key objective of the ACSD is to provide sophisticated risk models that can be used to assess outcomes and quality. Consequently, data elements are revised on a 3-year cycle to ensure they remain clinically relevant with evolving surgical practice and to address suggestions raised by data managers and surgeons. ACSD specification revision was a major focus in 2016 and entailed a systematic review of every data field in version 2.81. With each specification revision, there is always an inherent tension between collecting every possible relevant factor and increasing the number of data fields beyond a pragmatic size. An expansion pressure is also created by new technologies and procedures.
Mindful of maintaining this balance, outdated data elements have been eliminated in the most recent specification upgrade to permit inclusion of others that better reflect current and future practice. Most notably, the section on aortic and aortic root procedures was rewritten and substantially expanded to address the advances in aortic surgery since the last iteration of the database. The new version, which will become effective July 1, 2017, will contain approximately 1,200 data elements, including those data fields in the optional anesthesiology module. This represents an increase from the 840 fields in version 2.81, although the additional fields required for any given patient are far fewer because many of these data elements are child fields that are only relevant if the parent is selected; furthermore, some data elements apply only to specific types of patients.
National Outcomes in Adult Cardiac Surgery
This report encompasses aggregate outcomes for all operations performed during the period January 1 to December 31, 2015, and presented in the 2016 Harvest 1 report. They are based on the data elements specified in the current version (2.81) of the data collection instrument.
The relative distribution of the major procedures for which the STS ACSD has developed risk-adjustment models [3] [4] [5] and composite quality ratings [12] [13] [14] [15] is shown in Figure 1 . These seven procedures represent approximately 77% of the major cardiac procedures performed nationally. Thus, 23% of procedures performed nationally are not included in one of these seven categories and comprise procedures such as combined aortic and mitral valve replacement, tricuspid valve repair/ replacement, arrhythmia correction operations, implantation of a ventricular assist device, and septal defect repair, among others, that were performed in isolation or in combination with other procedures. Table 1 inventories the change in procedure volume during the past decade and the past year. The number of isolated CABG operations, although declining by 7% during the past decade, has shown a slight increase during the past year. This may reflect a change in the volume or treatment strategy, or both, of diabetic patients presenting with 3-vessel coronary disease. The volume of aortic valve replacements performed during the past decade has increased by 74%. However, that growth trend was notably absent during this past year, with a 1% decrease in the number of procedures, undoubtedly resulting from the effect of transcatheter aortic valve replacement as an emerging treatment option. There is a continuing national trend in favor of mitral valve repair over replacement [15] , although the overall number of procedures involving the mitral valve, despite showing growth during the past decade, decreased slightly in 2015. Selected aggregate national outcomes for the more commonly performed operations in calendar year 2015 are presented in Table 2 . Operative mortality for the listed procedures remains fundamentally unchanged from last year's report, ranging from a high of 9.8% for mitral valve replacement (MVR) combined with CABG (MVRþCABG) to a low of 1.1% for mitral valve repair. MVRþCABG continues to show the highest incidence of major morbidity among the most commonly performed procedures.
The incidence of new postoperative atrial fibrillation ranges from 24% for CABG to 44.2% for MVRþCABG.
Atrial fibrillation is the most frequently encountered complication after cardiac operations. It negatively affects postoperative clinical outcomes and resource utilization [16] and remains an area for quality improvement efforts.
The recognition that exposure to even small quantities of a transfused blood product can be associated with adverse short-term and long-term outcomes has led many cardiac surgical programs to adopt strategies to reduce transfusion. Table 3 details rates of blood product use for the past 2 calendar years. Transfusion rates have decreased for all of the seven major cardiac surgical procedures. During the past 5 years, transfusion rates have decreased by 10% to 15% [17] . Nevertheless, a substantial number of patients still are exposed to a blood product, highlighting the need for further efforts in this area.
Reducing readmissions has become a major health care reform goal, and the Centers for Medicare and Medicaid Services is introducing reimbursement penalties for higher-than-expected readmission rates after CABG. In 2015, the 30-day postdischarge readmission rates ranged from 10% for CABG to 16.1% for MVRþCABG (Table 3) . The three most common reasons for readmission are congestive heart failure, arrhythmias, and pleural effusions requiring treatment. The STS remains proactive in this area and has introduced a 30-day readmission measure for CABG [18] and produced a quality Webinar on this topic in May 2016.
Quality Measurement
The development of risk models and performance measures falls under the domain of the STS Quality 
Risk Models
A major focus of the QMTF in 2016 has been the development of new risk models for isolated CABG, isolated valve replacement operations, and valve replacement combined with CABG operations. Surgeons and statisticians reviewed the existing risk models and variables, as well as new variables available in version 2.73. They considered the clinical justification and importance of each variable, the relative frequency of each risk factor in the specific procedural population, the bivariate association of each variable with the nine relevant outcomes for each procedure, and the extent of missing data (or test not performed). Candidate variables were sequentially studied using backward selection at various levels of statistical significance, various tests of model discrimination and calibration were performed, and final models were developed. These new models will be published in 2017 and implemented in subsequent performance measures and feedback reports.
Composite Performance Measures for Mitral Valve Repair and Replacement, With or Without CABG
In 2016, STS QMTF added two new mitral composite measures, the isolated mitral valve repair or replacement (MVRR) composite [15] and MVRRþCABG composite [19] . Because contemporary mitral operations are frequently performed in conjunction with concomitant procedures, the MVRR and MVRRþCABG models were designed using modified versions of existing risk models to account for these additional procedures. Consequently, the STS mitral composite measures include all isolated mitral procedures as well as those undergoing concomitant tricuspid valve repair (not replacement), atrial septal defect and patent foramen ovale closure, and surgical ablation for atrial fibrillation. The performance of these common adjunctive procedures did not affect risk-adjusted mortality.
Because mitral valve pathophysiology can affect clinical decision making, particularly in patients with functional ischemic mitral regurgitation [20, 21] , the MVRRþCABG composite specifically examined the effect of mitral etiology on outcome. Etiology was found not to be an independent predictor of risk-adjusted 30-day mortality or major morbidity and was not included in the model. This finding does not refute the contribution of mitral etiology to the longer-term outcomes of mitral operations. Rather, As with previously developed STS composite measures, and in the absence of widely accepted or NQF-endorsed process measures for mitral valve operations, the primary end points assessed were 30-day or in-hospital mortality and the occurrence of major morbidity (reoperation, stroke, renal failure, sternal infection, or prolonged ventilation). After exclusions, 61,201 patients from 867 participating sites who underwent operations between July 2011 and June 2014 were identified for MVRR composite measure development [15] . The MVRRþCABG cohort included 24,740 MVRRþCABG patients from 703 participating sites. To provide composite scores to as many sites as possible while maintaining acceptable model reliability, the measures include 3 years of data from programs with at least 36 MVRR cases and at least 25 MVRRþCABG cases to arrive at a reliability of 0.58 and 0.50, respectively. For the MVRR measure, 2.6% of participant sites were deemed to be 1 star (lower-thanexpected performance), 91.7% were 2 stars (as-expected performance), and 5.7% were 3 stars (higher-than-expected performance). For the MVRRþCABG measure, 2% of programs were 1 star, 95% were 2 stars, and 3% were 3 stars. Deaths and morbidity progressively declined as star ratings increased. The MVRR and the MVRRþCABG measures were both reviewed favorably and recommended for endorsement by the NQF Surgery Project Standing Committee in 2016, and data from these composites will be delivered in participant feedback reports commencing in 2017.
Failure to Rescue
Failure to rescue (FTR) is a measure of hospital performance that is receiving increasing attention. It refers to the outcome of patients who have experienced a complication and focuses more on the system of care rather than the operative procedure. Superior FTR rates suggest that an institution has the staff, structures, and processes of care that allows it to better "rescue" patients who have sustained serious complications.
The STS has made considerable progress in the exploration of FTR. The STS National Database was used to develop FTR data for a contemporary cohort of CABG patients. Data from 604,154 patients undergoing CABG from 2010 to 2013 were used to develop a statistical model to predict FTR for each of four complications and for a composite of all four complications [22] . The STS analysis was consistent with previous studies showing that FTR rates were more strongly correlated with death than were overall complication rates.
Interestingly, when centers were grouped by terciles of complication rates, lower complication rates were associated with higher FTR and higher complication rates were associated with lower FTR. Likewise, the FTR observed-to-expected ratio was more favorable for the high-complication tercile and less favorable for the lowcomplication tercile. This apparent paradox has been addressed by the QMTF and will be explored. Each complication tercile is to be examined for volume, average patient risk, and other factors that may affect the findings. This closer examination of the complication terciles may shed light on the cause of the inverse relationship between complication rate and FTR.
Other areas to be explored are FTR rates for valve replacement operations, FTR outcomes other than death, and the complex determinants of FTR. As FTR studies progress, the STS hopes that the role of FTR can be more clearly defined and that STS members can be provided with a valuable new quality metric.
Quality Initiatives
The STS Task Force on Quality Initiatives (TQI) has devoted its energies primarily in three areas during the past year: (1) the development and maintenance of NQFendorsed measures (in collaboration with the QMTF); (2) the development of quality Webinars; and (3) providing surgeon support for Data Manager Regional Groups.
NQF Measure Submissions
The NQF is a multistakeholder organization whose goal is to improve health care quality through better measurement. NQF endorsement is the gold standard for health care quality, and NQF-endorsed measures are recognized as evidenced based and "best in class." The STS is committed to the development and use of such highestquality performance measures, and its 34 NQF-endorsed measures are the largest number of any professional society.
The submission of STS measures for NQF endorsement is a joint effort between the TQI and QMTF. The TQI specifically contributes information on clinical practice guidelines and other information to demonstrate that each measure focus is evidence based. In June 2016, the STS submitted three previously endorsed adult cardiac and three new adult cardiac composite measures to the NQF for review under the NQF Surgery Project Phase 3 ( Table 4 ). The NQF Surgery Project Standing Committee recommended all of the STS measures for endorsement at its August 2016 meeting, and it is anticipated that these measures will successfully undergo the remaining steps in the NQF measure review process, which includes 30-day NQF public and member comment period, postcomment review call, 15-day member voting period, endorsement decision by the Consensus Standards Approval Committee, and ratification by the NQF Board of Directors.
STS Quality Webinars
The first Webinar in the series debuted in 
Data Manager Regional Groups
STS National Database data managers remain vital to the ongoing success of the STS National Database. Data manager regional groups have provided a collaborative environment for peer support and guidance. There are now 20 such regional groups that span 43 states. Although surgeon participation has improved in several localities during the past year, only the groups in Virginia, Michigan, Texas/ Oklahoma, Maryland, and the Delaware Valley (consisting of programs in Pennsylvania, Delaware, and New Jersey) hold regular meetings attended by both surgeons and data managers. However, surgeon support, unfortunately, remains informal and unstructured throughout many areas of the country. There is little or no surgeon support of the Arkansas/Kentucky/Tennessee and Nebraska/Iowa regional data manager groups. The ACSD Task Force takes this opportunity to remind all cardiothoracic surgeons of their professional obligation to provide support for these critically important local quality improvement initiatives.
To highlight the important role of data mangers, the June 2016 issue of STS National Database News included a TQI article [23] that stressed the importance of data manager and surgeon collaboration in regional groups and featured the regional group activities in Texas and Michigan. In addition, the TQI provides data manager groups with expert speakers who are available to present on topics related to quality at regional meetings and calls. TQI surgeon members delivered presentations on quality improvement in acute kidney injury/acute renal failure at the August 2016 Missouri/Kansas regional group call and on successful regional quality collaboratives at the October 2016 Ohio regional group conference. The TQI will continue to work with Data Managers Regional Groups on this important initiative.
Future Initiatives
The ACSD will make operational the new specification revision (version 2.9) effective July 1, 2017. The audit process will use a 98% data completeness threshold for operative mortality fields submitted on or after January 1, 2017. Data collection and reporting methodology will be updated to better meet the needs of participants by implementing continuous data collection in January 2017 and a Web-based report dashboard in mid-2017. Volume thresholds for mitral valve repair will be explored, using data used to develop the STS mitral composite measures The development of risk models for short-term (periprocedural) and long-term (1-year and 5-year) costs for CABG Published results from states with cardiac surgery report cards will be compared with results from the STS Adult Cardiac Surgery Database for similar periods to examine the correlation of state report cards and STS performance ratings as well as the potential effect of public reporting on performance A multiprocedural composite will be developed to provide a more comprehensive perspective on hospital or group performance, based on the methodology used to develop the STS individual surgeon performance measure Explore the consistency of STS performance ratings over time as a potential adjunct to performance measurement Explore the issue of whether or not to adjust outcomes for socioeconomic status using geocoded STS data for adult cardiac surgery CABG ¼ coronary artery bypass grafting; STS ¼ The Society of Thoracic Surgeons.
The QMTF has planned a number of Adult Cardiac projects for the coming year. These projects are detailed in Table 5 .
Finally, the TQI continues to develop a proposal for a site review quality-improvement program. Volunteer TQI members have populated three workgroups focusing on previsit preparation and the in-person visit, postvisit reporting, and development of best practices. It is anticipated that such a program would facilitate interaction between adult cardiac surgical programs requesting external review and STS-approved site reviewers who have the demonstrated skills and attributes to assist in quality improvement. The program proposal is intended to be presented to the STS Board in early 2017.
Summary
Cardiothoracic surgeons were among the first medical specialists to recognize the value of comprehensive, accurate, and granular clinical information in their ongoing efforts to improve the care they provide to their patients. For nearly 30 years, the STS ACSD has been the foundation of the Society's activities in performance measurement, quality improvement, and outcomes research in adult cardiac surgery. Knowledge derived from the ACSD has advanced cardiac surgical care, improved patient outcomes, and helped to inform public policy. Future enhancements to the ACSD will remain devoted to these goals.
